Hello everyone,

I am currently working on a sandwich ELISA and have encountered an issue I’d like some insight on. My assay is consistently showing higher signal in the non-diseased control serum samples compared to the diseased samples, which is the opposite of what I would expect. I’ve double-checked my capture/detection antibody setup and plate preparation steps, but the trend persists. Has anyone experienced similar outcomes, and could this be due to matrix effects, endogenous biotin/avidin interactions, or other serum-related factors? I would greatly appreciate any suggestions on possible causes and troubleshooting strategies.

Thank you in advance!

More Brandon Hanna's questions See All
Similar questions and discussions